BioNTech (BNTX) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (08:30)
Sector: HealthcareThe share price of BioNTech SE (BNTX) now
50/200 Day Moving Average: $100.37 / $111.86
This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.
For BioNTech stocks, the 200-day moving average is the resistance level today.
Are you interested in BioNTech SE stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioNTech stock price in 2024, 2025, 2026, 2027, 2028. How much will one BioNTech share be worth in 2024 - 2028?
When should I take profit in BioNTech stock? When should I record a loss on BioNTech stock? What are analysts' forecasts for BioNTech stock? What is the future of BioNTech stock? We forecast BioNTech stock performance using neural networks based on historical data on BioNTech stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BioNTech stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioNTech shares. This happens once a day.
Historical and forecast chart of BioNTech stock
The chart below shows the historical price of BioNTech stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioNTech stock price can be found in the table below.
Long-term forecasts by years.
BioNTech SE is a German biotechnology company that develops and manufactures active immunotherapeutic agents for an individual approach to the treatment of serious diseases. The company is investigating messenger RNA (mRNA) -based drugs for use as individualized immunotherapy for cancer, as vaccines against infectious diseases and as protein replacement therapy for rare diseases, as well as developed cell therapy, new antibodies and small molecules, immunomodulators, as options cancer treatment. The company has developed an intravenous mRNA-based human therapeutic drug to bring individualized mRNA-based cancer immunotherapy to clinical trials and establish its own manufacturing process.
BioNTech daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 99.69 | 98.19 | 102.86 | 4.75 |
| Dec 06 | 97.66 | 96.42 | 99.06 | 2.73 |
| Dec 07 | 92.50 | 90.00 | 94.72 | 5.24 |
| Dec 08 | 92.83 | 90.05 | 96.34 | 6.99 |
| Dec 09 | 92.00 | 89.40 | 94.04 | 5.19 |
| Dec 10 | 94.92 | 90.82 | 99.19 | 9.22 |
| Dec 11 | 96.57 | 94.43 | 100.57 | 6.50 |
| Dec 12 | 98.72 | 96.17 | 102.98 | 7.08 |
| Dec 13 | 101.21 | 99.50 | 102.91 | 3.42 |
| Dec 14 | 99.38 | 97.95 | 101.23 | 3.35 |
| Dec 15 | 96.16 | 92.12 | 98.88 | 7.33 |
| Dec 16 | 98.47 | 94.75 | 100.84 | 6.42 |
| Dec 17 | 95.75 | 91.90 | 99.66 | 8.44 |
| Dec 18 | 96.67 | 95.34 | 100.91 | 5.84 |
| Dec 19 | 101.60 | 99.71 | 105.69 | 5.99 |
| Dec 20 | 103.07 | 99.05 | 107.09 | 8.12 |
| Dec 21 | 101.27 | 96.59 | 105.22 | 8.93 |
| Dec 22 | 104.62 | 103.11 | 108.07 | 4.81 |
| Dec 23 | 104.93 | 102.22 | 107.26 | 4.93 |
| Dec 24 | 103.42 | 99.45 | 106.83 | 7.42 |
| Dec 25 | 104.97 | 101.82 | 107.24 | 5.32 |
| Dec 26 | 99.93 | 95.85 | 101.55 | 5.94 |
| Dec 27 | 103.65 | 99.05 | 106.63 | 7.66 |
| Dec 28 | 101.04 | 96.43 | 104.31 | 8.17 |
| Dec 29 | 105.46 | 102.80 | 110.08 | 7.08 |
| Dec 30 | 102.36 | 100.27 | 105.98 | 5.70 |
| Dec 31 | 98.61 | 96.60 | 100.86 | 4.41 |
| Jan 01 | 96.96 | 94.63 | 98.47 | 4.06 |
| Jan 02 | 95.10 | 91.22 | 97.61 | 7.01 |
| Jan 03 | 96.41 | 93.63 | 97.57 | 4.20 |
BioNTech Daily Price Targets
BioNTech Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $99.69.
Positive dynamics for BioNTech shares will prevail with possible volatility of 4.536%.
Pessimistic target level: 98.19
Optimistic target level: 102.86
BioNTech Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $97.66.
Negative dynamics for BioNTech shares will prevail with possible volatility of 2.662%.
Pessimistic target level: 96.42
Optimistic target level: 99.06
BioNTech Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $92.50.
Negative dynamics for BioNTech shares will prevail with possible volatility of 4.980%.
Pessimistic target level: 90.00
Optimistic target level: 94.72
BioNTech Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $92.83.
Positive dynamics for BioNTech shares will prevail with possible volatility of 6.533%.
Pessimistic target level: 90.05
Optimistic target level: 96.34
BioNTech Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $92.00.
Negative dynamics for BioNTech shares will prevail with possible volatility of 4.931%.
Pessimistic target level: 89.40
Optimistic target level: 94.04
BioNTech Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $94.92.
Positive dynamics for BioNTech shares will prevail with possible volatility of 8.440%.
Pessimistic target level: 90.82
Optimistic target level: 99.19
BNTX (BNTX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 103.22 | 98.88 | 111.39 | 11.23 |
| Feb. | 107.18 | 98.05 | 117.34 | 16.44 |
| Mar. | 102.42 | 98.73 | 111.52 | 11.46 |
| Apr. | 91.61 | 84.68 | 94.13 | 10.04 |
| May. | 84.46 | 76.45 | 91.66 | 16.59 |
| Jun. | 88.11 | 80.71 | 93.40 | 13.58 |
| Jul. | 84.30 | 78.74 | 92.19 | 14.59 |
| Aug. | 85.72 | 78.00 | 87.78 | 11.13 |
| Sep. | 81.50 | 76.51 | 84.73 | 9.70 |
| Oct. | 72.21 | 66.41 | 77.67 | 14.50 |
| Nov. | 69.78 | 63.17 | 72.30 | 12.63 |
| Dec. | 71.29 | 67.27 | 73.52 | 8.50 |
BioNTech forecast for this year
BioNTech Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $103.217. Pessimistic: $98.88. Optimistic: $111.39
BioNTech Stock Prediction for Feb 2024
An uptrend is forecast for this month with an optimal target price of $107.18. Pessimistic: $98.05. Optimistic: $117.34
BioNTech Stock Prediction for Mar 2024
An downtrend is forecast for this month with an optimal target price of $102.422. Pessimistic: $98.73. Optimistic: $111.52
BioNTech Stock Prediction for Apr 2024
An downtrend is forecast for this month with an optimal target price of $91.6059. Pessimistic: $84.68. Optimistic: $94.13
BioNTech Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $84.4607. Pessimistic: $76.45. Optimistic: $91.66
BioNTech Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $88.1094. Pessimistic: $80.71. Optimistic: $93.40
BioNTech Stock Prediction for Jul 2024
An downtrend is forecast for this month with an optimal target price of $84.3031. Pessimistic: $78.74. Optimistic: $92.19
BioNTech Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $85.7194. Pessimistic: $78.00. Optimistic: $87.78
BioNTech Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $81.502. Pessimistic: $76.51. Optimistic: $84.73
BioNTech Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $72.2107. Pessimistic: $66.41. Optimistic: $77.67
BioNTech Stock Prediction for Nov 2024
An downtrend is forecast for this month with an optimal target price of $69.7845. Pessimistic: $63.17. Optimistic: $72.30
BioNTech Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $71.2918. Pessimistic: $67.27. Optimistic: $73.52
BioNTech (BNTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 72.40 | 68.32 | 78.23 | 12.66 |
| Feb | 69.80 | 64.69 | 75.16 | 13.93 |
| Mar | 76.67 | 74.64 | 81.36 | 8.25 |
| Apr | 83.57 | 81.46 | 85.97 | 5.25 |
| May | 80.46 | 75.82 | 84.61 | 10.38 |
| Jun | 86.64 | 81.96 | 91.11 | 10.04 |
| Jul | 91.21 | 86.28 | 94.06 | 8.26 |
| Aug | 83.33 | 75.43 | 85.93 | 12.22 |
| Sep | 74.53 | 67.73 | 80.16 | 15.51 |
| Oct | 72.65 | 68.64 | 76.40 | 10.16 |
| Nov | 69.34 | 65.10 | 73.58 | 11.53 |
| Dec | 70.84 | 65.57 | 77.55 | 15.45 |
BioNTech (BNTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 73.56 | 69.58 | 80.18 | 13.21 |
| Feb | 74.97 | 69.66 | 78.48 | 11.23 |
| Mar | 73.08 | 68.43 | 76.24 | 10.24 |
| Apr | 65.10 | 61.43 | 69.71 | 11.88 |
| May | 69.01 | 64.12 | 73.23 | 12.44 |
| Jun | 67.10 | 63.96 | 71.85 | 10.98 |
| Jul | 62.19 | 60.40 | 64.80 | 6.79 |
| Aug | 62.71 | 59.78 | 66.47 | 10.08 |
| Sep | 66.25 | 60.68 | 71.18 | 14.74 |
| Oct | 65.69 | 63.64 | 70.58 | 9.83 |
| Nov | 68.06 | 63.81 | 73.53 | 13.22 |
| Dec | 70.75 | 66.00 | 74.40 | 11.30 |
BioNTech (BNTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 73.47 | 68.97 | 75.50 | 8.64 |
| Feb | 81.67 | 75.89 | 86.08 | 11.84 |
| Mar | 84.80 | 80.94 | 92.54 | 12.54 |
| Apr | 81.34 | 76.17 | 88.18 | 13.62 |
| May | 82.91 | 78.23 | 85.00 | 7.96 |
| Jun | 83.50 | 75.59 | 88.01 | 14.12 |
| Jul | 82.00 | 78.56 | 87.12 | 9.83 |
| Aug | 90.66 | 83.15 | 98.49 | 15.57 |
| Sep | 85.55 | 80.11 | 90.06 | 11.06 |
| Oct | 85.75 | 82.46 | 93.67 | 11.97 |
| Nov | 81.02 | 74.21 | 83.74 | 11.38 |
| Dec | 87.43 | 82.82 | 89.74 | 7.72 |
BioNTech (BNTX) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 86.28 | 80.69 | 92.70 | 12.96 |
| Feb | 85.35 | 81.97 | 91.70 | 10.61 |
| Mar | 80.94 | 74.92 | 85.61 | 12.48 |
| Apr | 71.81 | 69.92 | 77.07 | 9.28 |
| May | 72.07 | 69.30 | 76.83 | 9.79 |
| Jun | 68.18 | 62.21 | 74.73 | 16.75 |
| Jul | 65.40 | 60.30 | 70.74 | 14.76 |
| Aug | 67.75 | 63.85 | 69.62 | 8.29 |
| Sep | 65.23 | 60.30 | 69.62 | 13.38 |
| Oct | 64.37 | 60.05 | 66.84 | 10.17 |
| Nov | 61.51 | 55.90 | 67.05 | 16.62 |
| Dec | 62.18 | 59.34 | 64.27 | 7.66 |
BioNTech information and performance
AN DER GOLDGRUBE 12, MAINZ, DE
Market capitalization of the BioNTech SE is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BNTX shares in the company outstanding by the market price of one share.
EBITDA of BioNTech is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
BioNTech (BNTX) stock dividend
BioNTech last paid dividends on 06/02/2022. The next scheduled payment will be on 06/17/2022. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
